I cannot understand why we don't use a 17a-estradiol to treat hairloss. In COSMO study we clearly see that 17a-estradiol (alfatradiol) is very good 5?-reductase inhibitor - efficiency is close to the CB-03-01. On the market all we have it's only 0.025% solution (example Pantostin) - in study of CB they use 1% solution. I can't understand why they used 17a-estradiol not for example RU58841. Can someone give me answers for my questions:
1. Why on the market we have only 0.025%?
2. From where COSMO have information that 1% of alfatradiol it's very good to test with the new potential androgen antagonist?
3. Why all of us making 2-5% solution of RU58841 but not a 1% alfatradiol solution (we have great small study from COSMO)?
Link for compare
I used alfatradiol for two months (to short to see benefits) and back to finasteride (because i saw recession) but it's weak concetration of 17a-estradiol (forty times smaller).
Thanks for response
1. Why on the market we have only 0.025%?
2. From where COSMO have information that 1% of alfatradiol it's very good to test with the new potential androgen antagonist?
3. Why all of us making 2-5% solution of RU58841 but not a 1% alfatradiol solution (we have great small study from COSMO)?
Link for compare
I used alfatradiol for two months (to short to see benefits) and back to finasteride (because i saw recession) but it's weak concetration of 17a-estradiol (forty times smaller).
Thanks for response